Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference

Eli Lilly (NYSE:LLY) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.

Rhea-AI Summary

Eli Lilly (NYSE:LLY) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health, will join a fireside chat at 3:20 p.m. Eastern time.

A live audio webcast and a 90-day replay will be available on Lilly's investor website in the Webcasts & Presentations section.

Argus May 27 session

+1.71% close to close Open Argus

Details

News Market Reaction – LLY

On May 27, the day this news came out, LLY closed 1.71% above the previous close.

Data tracked by StockTitan Argus for the May 27 session.

Market Context

This announcement highlights LLY’s upcoming participation in a major healthcare investor conference ...

Analysis

This announcement highlights LLY’s upcoming participation in a major healthcare investor conference on June 9, 2026, with a fireside chat at 3:20 p.m. ET and a webcast archive available for 90 days. It fits a recent pattern of frequent investor and scientific visibility alongside notable clinical and acquisition updates. Key factors to monitor include how management frames recent obesity, cardiometabolic, and oncology developments and whether new strategic details emerge during the session.

Key Figures

Conference edition: 47th Annual Conference date: June 9, 2026 Event time: 3:20 p.m. ET +1 more

Conference edition

47th Annual

Goldman Sachs Global Healthcare Conference

Conference date

June 9, 2026

LLY scheduled fireside chat

Event time

3:20 p.m. ET

Scheduled time of fireside chat

Replay window

90 days

Webcast replay availability on investor website

Historical Context

5 past events · Latest: May 26

5 events

1. May 26

   Portfolio acquisitions

   24h Move

   -0.0%

   Announced three vaccine-focused acquisitions to expand infectious disease portfolio.

2. May 25

   Clinical data update

   24h Move

   -0.0%

   Interim Phase 1b data for VERVE-102 showed strong LDL-C and PCSK9 reductions.

3. May 21

   Oncology conference plans

   24h Move

   +2.2%

   Detailed ASCO plans highlighting Phase 3 data and multiple oncology programs.

4. May 21

   Obesity Phase 3 data

   24h Move

   +2.2%

   Topline Phase 3 TRIUMPH-1 results showed large weight loss with retatrutide.

5. May 18

   Investor conference

   24h Move

   -1.7%

   Announcement of a Bernstein fireside chat and webcast availability for investors.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

webcast

1 terms

webcast technical

"A live audio webcast will be available on the "Webcasts & Presentations" section"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

INDIANAPOLIS, May 27, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health, will take part in a fireside chat at 3:20 p.m. Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.

About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY

Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

Refer to:	Megan MacCauley; maccauley_megan@lilly.com; 463-202-1516 (Media)
	Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors)

View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-goldman-sachs-47th-annual-global-healthcare-conference-302783288.html

SOURCE Eli Lilly and Company

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Eli Lilly (LLY) present at the Goldman Sachs 47th Annual Global Healthcare Conference?

Eli Lilly will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. According to Lilly, a fireside chat featuring Kenneth Custer starts at 3:20 p.m. Eastern time for investors to follow.

Who will represent Eli Lilly (LLY) at the Goldman Sachs Global Healthcare Conference 2026?

Eli Lilly will be represented by Kenneth Custer, executive vice president and president, Lilly Cardiometabolic Health. According to Lilly, he will take part in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference.

How can investors listen to Eli Lilly's (LLY) fireside chat at the Goldman Sachs 2026 healthcare conference?

Investors can listen via a live audio webcast on Lilly's investor website. According to Lilly, the stream is available in the Webcasts & Presentations section for convenient real-time access on June 9, 2026.

Will a replay of Eli Lilly's (LLY) Goldman Sachs 2026 conference presentation be available?

Yes, a replay of Eli Lilly's fireside chat will be available for about 90 days. According to Lilly, investors can access the replay on the same Webcasts & Presentations page of its investor relations website.

Where is the webcast link for Eli Lilly's (LLY) June 9, 2026 Goldman Sachs conference appearance?

The webcast link is on Lilly's investor website under Webcasts & Presentations. According to Lilly, both the live audio webcast and replay can be accessed through this dedicated investor relations page.